ABE1943MI

MilliporeSigma™ Rabbit anti-HOXB13, Polyclonal,

Manufacturer: MilliporeSigma™

Select a Size

Pack Size SKU Availability Price
Each of 1 ABE1943MI-Each-of-1 In Stock ₹ 41,813.98

ABE1943MI - Each of 1

₹ 41,813.98

In Stock

Quantity

1

Base Price: ₹ 41,813.98

GST (18%): ₹ 7,526.516

Total Price: ₹ 49,340.496

Antigen

HOXB13

Classification

Polyclonal

Gene Accession No.

Q92826

Host Species

Rabbit

Purification Method

Affinity Purified

Regulatory Status

RUO

Primary or Secondary

Primary

Target Species

Human

Applications

Immunocytochemistry, Immunohistochemistry, Western Blot

Formulation

Purified rabbit polyclonal antibody in buffer containing 0.1M Tris-HCI, pH 8.0, and 0.1% soidum azide.

Gene Symbols

HOXB13

Immunogen

KLH-conjugated linear peptide corresponding to the C-terminus of human HOXB13.

Quantity

100 μg

Research Discipline

Epigenetics and Nuclear Function

Gene ID (Entrez)

NP_006352

Content And Storage

Stable for one year at 2°C to 8°C from date of receipt.

Related Products

Img

MilliporeSigma™

ABE1408MI

--

Img

MilliporeSigma™

ABN1038MI

--

Img

MilliporeSigma™

ABE1313MI

--

Img

MilliporeSigma™

ABE1310MI

--

Img

MilliporeSigma™

ABC924MI

--

Img

MilliporeSigma™

ABE1844MI

--

Img

MilliporeSigma™

ABT251MI

--

Img

MilliporeSigma™

ABE1307MI

--

Description

  • Specifically detects HOXB13 in Human samples, and it is validated for Immunocytochemistry, Immunohistochemistry, Western Blotting Homeobox protein Hox-B13 (UniProt Q92826) is encoded by the HOXB13 (also known as PSGD) gene (Gene ID 10481) in human
  • HOXB13 is a homeobox gene family member whose expression is restricted to prostate tissues and is highly correlated with that of androgen receptor (AR)
  • Hox-B13 suppresses androgen-stimulated AR activity via direct AR interaction and thereby inhibits androgen-dependent (AD) prostate cancer (PCa) growth under androgen-rich conditions
  • On the other hand, HOXB13 is also known to be over-expressed in castration-resistant PCa (CRPC), where it plays a dichotomic role in promoting androgen-independent (AI) PCa growth
  • The zinc level in human prostate is markedly diminished in prostatic epithelial tumors and continues to decline during progression towards AI growth
  • HOXB13 over-expression upregulates transcription of its target genes SLC30A10 (ZnT10) and SLC30A4 (ZnT4) for zinc output transporters, which are responsible for the reduction in zinc level in CRPC
  • The diminished intracellular zinc level in turn stimulates NF-κB signaling and promotes invasion and metastasis of CRPC cells.